Generation and characterization of mesenchymal stromal cells for clinical application

被引:1
|
作者
Sensebe, L. [1 ]
机构
[1] EFS Ctr Atlantique, Dept Res, Tours 3, France
关键词
clinical trials; controls; GMP; Mesenchymal Stem Cells; HUMAN BONE-MARROW; UMBILICAL-CORD BLOOD; ADULT STEM-CELLS; HUMAN ADIPOSE-TISSUE; EX-VIVO EXPANSION; IN-VITRO; PROGENITOR CELLS; OSTEOGENESIS IMPERFECTA; T-CELLS; GROWTH;
D O I
10.1111/j.1751-2824.2009.01225.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mesenchymal Stem Cells/Multipotent Marrow Stromal Cells (MSC) are multipotent adult stem cells harboring a wide range of differentiation capacities as well as non-HLA restricted immunosuppressive properties, leading to an increase in their uses for immunomodulation and regenerative medicine. MSC are generally cultivated from bone marrow (BM). Alternative sources (e.g. adipose tissue or umbilical cord) are rapidly developing. Considering the starting material used, the differentiation potential may be different, in example adipose tissue derived MSC exhibit a greater potential for endothelium repair. Whatever the sources of MSC, a first step of adherence to plastic is required. When seeding, the cell density is of major importance acting on growth speed, cell amplification, and differentiation potential. Considering medium used, until now serum free media are not available to cultivate MSC for clinical application. Standard process with FCS without any growth factor supplementation is effective but time consuming, sometime failing, and not totally secure. Although processes using recombinant growth factors (e.g. FGF2) or platelet lysate have demonstrated their interest, definitive standards to produce clinical-grade MSC are still lacking. To reach GMP standards, two major steps have to be done. First, MSC cultures need to be done in closed system; this step is not easy to perform. Second, the controls of produced batches have to ensure efficacy and safety. Now, the controls are principally based on FACS analysis and the expected CD731(pos)CD105(pos)CD90(pos)CD45(neg) MSC phenotype is easily obtained. But the major problem remains the lack of fully validated controls of the final cell product efficacy and safety. Considering the genetic stability of MSC during culture processes, whatever the culture method, aneuploidy could occur during clinical-grade production of BM-MSC but does not lead to cell transformation. But these results should lead to develop more accurate and powerful controls of all MSC in cultures.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 50 条
  • [41] Challenges and advances in clinical applications of mesenchymal stromal cells
    Zhou, Tian
    Yuan, Zenan
    Weng, Jianyu
    Pei, Duanqing
    Du, Xin
    He, Chang
    Lai, Peilong
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [42] Adipose tissue-derived mesenchymal stromal cells for clinical application: An efficient isolation approach
    Lisini, D.
    Nava, S.
    Pogliani, S.
    Avanzini, M. A.
    Lenta, E.
    Bedini, G.
    Mantelli, M.
    Pecciarini, L.
    Croce, S.
    Boncoraglio, G.
    Maccario, R.
    Parati, E. A.
    Frigerio, S.
    [J]. CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2019, 67 (01) : 20 - 27
  • [43] Clinical and Future Application of Autologous Multipotential Mesenchymal Stromal Stem Cells for the Treatment of Neurological Diseases
    Slavin, S.
    Gesuntheid, B.
    Ashkenasi, N.
    Bakimer-Kleiner, R.
    Gowda-Kurkalli, B.
    Karageorgiou, C.
    Kronfeld, N.
    Cazacu, S.
    Finnins, S.
    Lee, H-K
    Brodie, C.
    [J]. HUMAN GENE THERAPY, 2010, 21 (05) : 646 - 646
  • [44] Production results of Mesenchymal Stromal Cells cultured in CellSTACKs and platelet-lysate for clinical application
    Westinga, K.
    van Gelder, M.
    Vonk-Griffioen, S.
    Leeflang, P.
    Wulffraat, N.
    Kuball, J.
    van den Broek, M.
    Slaper-Cortenbach, I.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : 5554 - 5554
  • [45] Dental Application Potential of Mesenchymal Stromal Cells and Embryonic Stem Cells
    Liu, Hua
    Cao, Tong
    [J]. CHINESE JOURNAL OF DENTAL RESEARCH, 2010, 13 (02): : 95 - 103
  • [46] Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells
    Luo, Lidan
    Zhou, Yan
    Zhang, Chenxi
    Huang, Jinrong
    Du, Jie
    Liao, Jinqi
    Bergholt, Natasja Leth
    Bunger, Cody
    Xu, Fengping
    Lin, Lin
    Tong, Guangdong
    Zhou, Guangqian
    Luo, Yonglun
    [J]. STEM CELL RESEARCH, 2020, 48
  • [47] Clinical Application of Induced Hepatocyte-like Cells Produced from Mesenchymal Stromal Cells: A Literature Review
    Bogliotti, Yanina
    Vander Roest, Mark
    Mattis, Aras N.
    Gish, Robert G.
    Peltz, Gary
    Anwyl, Robin
    Kivlighn, Salah
    Schuur, Eric R.
    [J]. CELLS, 2022, 11 (13)
  • [48] Stem cells out of the bag: characterization of ex vivo expanded mesenchymal stromal cells for possible clinical use
    Lopes, Sergio M.
    Roncon, Susana
    Bordalo, Filipa
    Amado, Fatima
    Ferreira, Sara
    Pinho, Ana C.
    Vieira, Joana
    Costa-Pereira, Altamiro
    [J]. FUTURE SCIENCE OA, 2020, 6 (03):
  • [49] Mesenchymal stromal cells
    Horwitz, Edwin M.
    Andreef, Michael
    Frassoni, Francesco
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (01) : 53 - 57
  • [50] Mesenchymal Stromal Cells
    Szala, Stanislaw
    Wisniewska, Ewa
    Matuszczak, Sybilla
    Czapla, Justyna
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2014, 68 : 1287 - 1298